Live News EQUITY FLASH L impact Oct 26, 2026, 10:26 AM UTC Johnson & Johnson Prostate Cancer Drug Shrinks Tumors in Early-Stage Study Johnson & Johnson's prostate cancer drug shrank tumors in an early-stage study. JNJ SquawkNews Desk